Fortress Biotech, Inc., formerly Coronado Biosciences, Inc., is a biopharmaceutical company. The Company is involved in the development of immunotherapy agents for the treatment of autoimmune diseases and cancer, which include CNDO-201 or Trichuris suis ova (TSO) and CNDO-109. The Company is engaged in planning, identifying, evaluating and acquire, in-license and invest in pharmaceutical and biotechnology products, technologies and companies. CNDO-201 is a biologic that consists of microscopic eggs of the porcine whipworm used in treatment of autoimmune diseases, such as Crohn’s disease (CD), ulcerative colitis (UC), multiple sclerosis (MS), autism, psoriasis and Type 1 diabetes. CNDO-109 is a biologic that activates the immune system’s natural killer, cells to seek and destroy cancer cells that cause hematologic malignancies, including myeloid leukemia and multiple myeloma, as well as breast, prostate and ovarian cancers.